The Middle EAST Biomaterials Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several factors, including increasing healthcare expenditures, the rising prevalence of chronic diseases, and advancements in biomaterials technology. The demand for biocompatible materials in medical...